Sign Up for Free!

Continue Analyzing the page and more.

Already have an Account? Log In

The Trial has ended

Continue Analyzing the page and more.

Tibet Rhodiola Pharmaceutical Holding Co logo

Tibet Rhodiola Pharmaceutical Holding Co

US$43.03

US$11.4b

4.37%

16.87%

Dashboard Funda..tals Deep..lue Prediction Screener Map

Tibet Rhodiola Pharmaceutical Holding Co Overview

Industry: Pharmaceuticals

Sector: Healthcare

Tibet Rhodiola Pharmaceutical Holding Co is evaluated using Mavefund's quality framework: growing earnings, durable profit margins, conservative leverage, strong return on equity, and disciplined share repurchases.

Score

Price History & Performance

Review Tibet Rhodiola Pharmaceutical Holding Co in context before unlocking the interactive price chart, financial overlays, and downloadable ratio tables.

Recent News



Tibet Rhodiola Pharmaceutical Holding Co Competitors

Tibet Rhodiola Pharmaceutical Holding Co operates in the Pharmaceuticals industry within the Healthcare sector. Unlock the full page to compare peer rankings, valuation quality, profitability, leverage, and growth trends.

Earnings Per Share

EPS quality is one of the core Mavefund signals. Sign up to continue into the detailed EPS, ROE, margin, share buyback, leverage, and financial ratio analysis.

Continue the analysis

Sign up to unlock ROE, net margin, share buyback, leverage, financial ratios, peer charts, and downloads.

View plans
Ticker Image

Tibet Rhodiola Pharmaceutical Holding Co

US$43.03

US$11.4b

4.37%

16.87%